SunTech Medical, Inc. Sustainability Profile
SunTech Medical, Inc., a leading innovator in the medical device industry, is headquartered in the United States. Founded in 1987, the company has established itself as a pioneer in non-invasive blood pressure monitoring solutions, catering to healthcare providers worldwide. With a strong presence in North America and Europe, SunTech Medical focuses on developing advanced technologies that enhance patient care and streamline clinical workflows. The company’s core products, including the renowned Tango+ and CT40 blood pressure monitors, are distinguished by their accuracy and ease of use, making them essential tools in both hospital and outpatient settings. SunTech Medical has garnered recognition for its commitment to quality and innovation, positioning itself as a trusted partner in the healthcare sector. With a rich history of milestones, SunTech continues to lead the way in non-invasive monitoring solutions, ensuring better outcomes for patients globally.
DitchCarbon Score
How does SunTech Medical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
SunTech Medical, Inc.'s score of 52 is higher than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
SunTech Medical, Inc., headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Halma plc, which may influence its climate commitments and reporting practices. While SunTech Medical has not established its own reduction targets or climate pledges, it is important to note that it inherits certain sustainability initiatives from Halma plc. This includes participation in the Carbon Disclosure Project (CDP) at a cascade level of 1, which suggests that the company aligns with broader corporate sustainability goals set by its parent organisation. As of now, SunTech Medical has not publicly committed to specific science-based targets or other industry-standard climate initiatives. The lack of detailed emissions data and reduction targets highlights an opportunity for the company to enhance its climate strategy and transparency in the future.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Scope 1 | 4,771,000 | 0,000,000 | - | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 14,043,000 | 00,000,000 | 00,000,000 | 00,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 17,281,000 | 00,000,000 | - | 0,000,000 | - | 00,000,000 | 000,000,000 | 000,000,000 |
How Carbon Intensive is SunTech Medical, Inc.'s Industry?
How Carbon Intensive is SunTech Medical, Inc.'s Location?
SunTech Medical, Inc.'s Scope 3 Categories Breakdown
SunTech Medical, Inc.'s Scope 3 emissions, which increased by 2% last year and increased significantly since 2018, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Use of Sold Products" being the largest emissions source at 52% of Scope 3 emissions.
Top Scope 3 Categories
SunTech Medical, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
SunTech Medical, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
